Sign in Pull a receipt

EOCN

Galmed Pharmaceuticals Ltd.

Healthcare · Biotechnology

$206.92 sample

+1.57 (+0.76%) 1D

Market cap

$501.7B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$206.92 +23.46% 3M daily closessample

209.27167.60

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: Director
Oct 16SEC8-K filed: material event
Oct 07INSInsider sell: Chief Financial Officer
Oct 02SECForm 144 filed
Sep 25INSInsider buy: Chief Executive Officer
Sep 16INSInsider buy: General Counsel
Sep 11INSInsider buy: EVP, Operations
Sep 08SECForm 144 filed

Sign up to see the real EOCN record →

Company facts

SEC EDGAR registration

Name: Galmed Pharmaceuticals Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +53sample, -100 to +100
Reporting currency: USD

Who is positioning in EOCN

sample

Insiders: 34 insider transactions over 90 days, net selling, $15.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 34 funds hold $10.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.3B +22.9% y/y

Q4 2024Q3 2026

Inventory$18.8B +3.4% y/y

Q4 2024Q3 2026

Accounts receivable$14.7B +18.7% y/y

Q4 2024Q3 2026

Total debt$38.2B +14.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $360.7B -5.0% 3M
Sample peer B: $318.7B -11.4% 3M
Sample peer C: $83.4B +11.4% 3M
Sample peer D: $284.3B +6.3% 3M
Sample peer E: $289.8B -1.3% 3M